share_log

翰森製藥:董事會召開日期

HKEX ·  Aug 15 04:48
Summary by Moomoo AI
翰森製藥集團有限公司宣布將於2024年8月27日(星期二)召開董事會會議,主要目的是考慮及通過截至2024年6月30日止六個月的中期業績,並討論建議的中期股息(如有)。此次會議也將處理其他事項。會議將由公司主席鍾慧娟女士主持,並有執行董事孫遠女士、呂愛鋒博士以及獨立非執行董事林國強先生、陳尚偉先生及楊東濤女士參與。
翰森製藥集團有限公司宣布將於2024年8月27日(星期二)召開董事會會議,主要目的是考慮及通過截至2024年6月30日止六個月的中期業績,並討論建議的中期股息(如有)。此次會議也將處理其他事項。會議將由公司主席鍾慧娟女士主持,並有執行董事孫遠女士、呂愛鋒博士以及獨立非執行董事林國強先生、陳尚偉先生及楊東濤女士參與。
Hansoh Pharma Group Limited has announced that it will hold a Board of Directors meeting on Tuesday, August 27, 2024, mainly to consider and approve the mid-term performance of the six months ending June 30, 2024, and discuss the proposed mid-term dividends (if any). Other matters will also be handled at this meeting. The meeting will be chaired by Ms. Zhong Huijuan, the Chairman of the company, and attended by Executive Directors Ms. Sun Yuan and Dr. Lv Aifeng, as well as Independent Non-executive Directors Mr. Lin Guoqiang, Mr. Chen Shangwei, and Ms. Yang Dongtao.
Hansoh Pharma Group Limited has announced that it will hold a Board of Directors meeting on Tuesday, August 27, 2024, mainly to consider and approve the mid-term performance of the six months ending June 30, 2024, and discuss the proposed mid-term dividends (if any). Other matters will also be handled at this meeting. The meeting will be chaired by Ms. Zhong Huijuan, the Chairman of the company, and attended by Executive Directors Ms. Sun Yuan and Dr. Lv Aifeng, as well as Independent Non-executive Directors Mr. Lin Guoqiang, Mr. Chen Shangwei, and Ms. Yang Dongtao.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more